BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 126582
Published online Nov 24, 2026. doi: 10.5306/wjco.126582
Table 1 Characteristics of the analyzed development and second-institution cohorts, mean ± SD/n (%)
Characteristic
Development cohort (n = 1035)
Second-institution cohort (n = 212)
Age, years47.78 ± 13.6848.88 ± 13.57
Sex
    Female457 (44.15)90 (42.45)
    Male578 (55.85)122 (57.55)
Location
    Upper extremity150 (14.49)31 (14.62)
    Lower extremity504 (48.70)95 (44.81)
    Trunk381 (36.81)86 (40.57)
Depth
    Superficial307 (29.66)60 (28.30)
    Deep728 (70.34)152 (71.70)
Tumor size, cm5.95 ± 4.236.39 ± 4.12
FNCLCC grade
    1464 (44.83)92 (43.40)
    2246 (23.77)48 (22.64)
    3325 (31.40)72 (33.96)
Surgical margin
    Negative952 (91.98)190 (89.62)
    Positive83 (8.02)22 (10.38)
Radiotherapy
    No658 (63.57)110 (51.89)
    Yes377 (36.43)102 (48.11)
Chemotherapy
    No793 (76.62)154 (72.64)
    Yes242 (23.38)58 (27.36)
Bone or neurovascular invasion
    No802 (77.49)163 (76.89)
    Yes233 (22.51)49 (23.11)
Unplanned surgery
    No822 (79.42)178 (83.96)
    Yes213 (20.58)34 (16.04)
Symptom duration, months24.66 ± 13.2124.86 ± 13.84
Local recurrence within 3 years331 (32.0)67 (31.60)


Write to the Help Desk